Cardlytics' Current Deferred Revenue rose 6057.14% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 6057.14%. This contributed to the annual value of $2.2 million for FY2024, which is 1043.66% down from last year.
Per Cardlytics' latest filing, its Current Deferred Revenue stood at $3.4 million for Q3 2025, which was up 6057.14% from $3.2 million recorded in Q2 2025.
Cardlytics' Current Deferred Revenue's 5-year high stood at $4.7 million during Q2 2022, with a 5-year trough of $259000.0 in Q1 2021.
Over the past 5 years, Cardlytics' median Current Deferred Revenue value was $2.8 million (recorded in 2021), while the average stood at $2.7 million.
As far as peak fluctuations go, Cardlytics' Current Deferred Revenue crashed by 5704.81% in 2021, and later surged by 110540.54% in 2022.
Over the past 5 years, Cardlytics' Current Deferred Revenue (Quarter) stood at $3.3 million in 2021, then crashed by 46.62% to $1.8 million in 2022, then skyrocketed by 37.35% to $2.4 million in 2023, then decreased by 10.44% to $2.2 million in 2024, then skyrocketed by 56.55% to $3.4 million in 2025.
Its Current Deferred Revenue stands at $3.4 million for Q3 2025, versus $3.2 million for Q2 2025 and $2.6 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value